Literature DB >> 18275561

Medico-legal assessment of disability in narcolepsy: an interobserver reliability study.

Francesca Ingravallo1, Luca Vignatelli, Martina Brini, Concetta Brugaletta, Christian Franceschini, Federica Lugaresi, Maria C Manca, Sergio Garbarino, Pasquale Montagna, Alberto Cicognani, Giuseppe Plazzi.   

Abstract

Impairment because of narcolepsy strongly limits job performance, but there are no standard criteria to assess disability in people with narcolepsy and a scale of disease severity is still lacking. We explored: (1) the interobserver reliability among Italian Medical Commissions making disability and handicap benefit decisions for people with narcolepsy, searching for correlations between the recognized disability degree and patients' features; (2) the willingness to report patients to the driving licence authority and (3) possible sources of variance in judgement. Fifteen narcoleptic patients were examined by four Medical Commissions in simulated sessions. Raw agreement and interobserver reliability among Commissions were calculated for disability and handicap benefit decisions and for driving licence decisions. Levels of judgement differed on percentage of disability (P < 0.001), severity of handicap (P = 0.0007) and the need to inform the driving licence authority (P = 0.032). Interobserver reliability ranged from Kappa = -0.10 to 0.35 for disability benefit decision and from Kappa = -0.26 to 0.36 for handicap benefit decision. The raw agreement on driving licence decision ranged from 73% to 100% (Kappa not calculable). Spearman's correlation between percentages of disability and patients' features showed correlations with age, daytime naps, sleepiness, cataplexy and quality of life. This first interobserver reliability study on social benefit decisions for narcolepsy shows the difficulty of reaching an agreement in this field, mainly because of variance in interpretation of the assessment criteria. The minimum set of indicators of disease severity correlating with patients' self assessments encourages a disability classification of narcolepsy.

Entities:  

Mesh:

Year:  2008        PMID: 18275561     DOI: 10.1111/j.1365-2869.2008.00630.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  7 in total

1.  The Humanistic and Economic Burden of Narcolepsy.

Authors:  Natalia M Flores; Kathleen F Villa; Jed Black; Ronald D Chervin; Edward A Witt
Journal:  J Clin Sleep Med       Date:  2016-03       Impact factor: 4.062

2.  Comparison of modafinil and pitolisant in narcolepsy: a non-inferiority meta-analytical approach.

Authors:  Philippe Lehert; Cassandra Szoeke
Journal:  Drugs Context       Date:  2020-07-08

3.  Narcolepsy: let the patient's voice awaken us!

Authors:  Julie Flygare; Sairam Parthasarathy
Journal:  Am J Med       Date:  2014-06-12       Impact factor: 4.965

4.  Use of a structured functional evaluation process for independent medical evaluations of claimants presenting with disabling mental illness: rationale and design for a multi-center reliability study.

Authors:  Monica Bachmann; Wout de Boer; Stefan Schandelmaier; Andrea Leibold; Renato Marelli; Joerg Jeger; Ulrike Hoffmann-Richter; Ralph Mager; Heinz Schaad; Thomas Zumbrunn; Nicole Vogel; Oskar Bänziger; Jason W Busse; Katrin Fischer; Regina Kunz
Journal:  BMC Psychiatry       Date:  2016-07-29       Impact factor: 3.630

Review 5.  Inter-rater agreement in evaluation of disability: systematic review of reproducibility studies.

Authors:  Jürgen Barth; Wout E L de Boer; Jason W Busse; Jan L Hoving; Sarah Kedzia; Rachel Couban; Katrin Fischer; David Y von Allmen; Jerry Spanjer; Regina Kunz
Journal:  BMJ       Date:  2017-01-25

6.  Independent medical evaluation for sick-listed patients: a focus group study of GPs´ expectations and experiences.

Authors:  Aase Aamland; Elisabeth Husabo; Silje Maeland
Journal:  BMC Health Serv Res       Date:  2018-08-29       Impact factor: 2.655

7.  Multiple treatment comparison in narcolepsy: a network meta-analysis.

Authors:  Philippe Lehert; Bruno Falissard
Journal:  Sleep       Date:  2018-12-01       Impact factor: 5.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.